• Quizartinib (AC220): Unlocking FLT3 Pathway Vulnerabilities

  2026-06-30

  Explore how Quizartinib (AC220) advances acute myeloid leukemia (AML) research by targeting FLT3 signaling vulnerabilities and resistance mechanisms. This article uniquely analyzes cross-disease relevance and practical assay optimization, delivering actionable insights for next-generation research.

• (5Z)-7-Oxozeaenol: TAK1 Inhibitor Workflows and Troubleshoot

  2026-06-29

  (5Z)-7-Oxozeaenol enables high-fidelity TAK1 inhibition for precise dissection of NF-κB and JNK/p38 MAPK signaling in inflammation, stress, and metabolic crosstalk models. This guide delivers actionable protocol parameters, troubleshooting insights, and next-generation workflow enhancements that leverage the latest mechanistic advances and APExBIO’s trusted quality.

• HO-1-Mediated ROS Modulation Blocks HBV Replication via ICAA

  2026-06-29

  This study demonstrates that isochlorogenic acid A (ICAA) disrupts hepatitis B virus (HBV) replication by modulating heme oxygenase-1 (HO-1) and intracellular reactive oxygen species (ROS). The findings highlight novel antiviral strategies targeting host redox pathways, offering new directions for metabolic and infectious disease research.

• PI3K/AKT/mTOR Inhibitor Combinations Enhance Anti-Angiogenes

  2026-06-28

  This study demonstrates that combining inhibitors targeting the PI3K/AKT/mTOR pathway, including LY294002, augments anti-angiogenic efficacy in vivo using zebrafish models of ocular neovascularization. The findings highlight the therapeutic potential of pathway-targeted drug combinations for safer and more effective intervention in diseases like AMD and diabetic retinopathy.

• ω-Agatoxin IVA TFA: Precision Tools for Synaptic and Epileps

  2026-06-27

  ω-Agatoxin IVA TFA empowers researchers with nanomolar-selective Cav2.1 channel blockade for dissecting synaptic transmission and neuroprotective mechanisms. Its distinct pharmacology enables high-fidelity neuronal calcium current recordings and translational epilepsy model optimization.

• Cyclic Pifithrin-α Hydrobromide: Precision p53 Inhibition Wo

  2026-06-26

  Cyclic Pifithrin-α hydrobromide empowers researchers to selectively dissect p53-dependent pathways—crucial for apoptosis studies and radioprotection modeling—by offering robust inhibition and workflow-friendly solubility. Leveraging recent advances in neuroinflammatory research, this compound delivers actionable control over complex cellular responses, facilitating high-reproducibility assays in cancer and beyond.

• AMPK–SQSTM1 Feedback Loop Synergizes Antioxidant Defense in

  2026-06-26

  This study reveals a novel double-positive feedback loop between AMPK and SQSTM1/p62, which drives dual activation of AMPK and NFE2L2/NRF2 under metabolic stress. The findings clarify how cancer cells adapt to hostile microenvironments and suggest new strategies for targeting redox regulation in tumor biology.

• BMS-345541: Precision IKK-1/IKK-2 Inhibition in Inflammation

  2026-06-25

  BMS-345541 enables selective, potent inhibition of IKK-1/IKK-2, supporting robust workflows in inflammation and cancer research. Its allosteric mechanism empowers precise NF-κB modulation, as recently leveraged in angiogenesis models to dissect cytokine signaling and cell fate.

• SM-102 Lipid Nanoparticles: Advancing mRNA Delivery Workflow

  2026-06-25

  SM-102 enables efficient mRNA encapsulation and delivery, crucial for next-generation vaccine and therapeutic workflows. Recent studies showcase its pivotal role in localized mRNA therapy, offering practical advantages and protocol enhancements for experimental design.

• Annexin V, human recombinant: Precision Phosphatidylserine P

  2026-06-24

  Annexin V, a phosphatidylserine binding protein, enables high-fidelity detection of early apoptosis by targeting PS externalization. Recombinant human Annexin V (K2064) from APExBIO offers robust, calcium-dependent binding and is validated for in situ and in vitro apoptosis assays. This dossier outlines its mechanism, evidence base, and workflow integration.

• Bifendate Inhibits Autophagy and Reduces Lipid Accumulation

  2026-06-23

  The reference study uncovers that Bifendate (DDB) inhibits autophagy at multiple stages, particularly autophagosome-lysosome fusion and lysosomal acidification, and attenuates oleic acid-induced lipid accumulation in vitro. These findings clarify DDB’s mechanistic role as a hepatoprotection agent and suggest new research directions for targeting hepatic lipid disorders.

• Cy7 NHS Ester: Technical Guide for Near-Infrared Protein Lab

  2026-06-23

  Cy7 NHS ester provides a solution for labeling sensitive proteins and peptides with a highly water-soluble, sulfonated near-infrared dye. It minimizes fluorescence quenching and protein denaturation risk, making it suitable for near-infrared fluorescent imaging and in vivo tracking. This product should be avoided for workflows that require prolonged solution storage or extreme chemical stability.

• Dasatinib Monohydrate: Advanced Kinase Inhibition in Tumor M

  2026-06-22

  Dasatinib Monohydrate (BMS-354825) empowers researchers to dissect resistance mechanisms and optimize targeted therapies in both classic leukemia and next-generation assembloid models. Discover protocol enhancements, troubleshooting strategies, and how to leverage patient-derived tumor microenvironments for translational breakthroughs.

• BKT140 (BL-8040): Defining CXCR4 Antagonism in Theranostics

  2026-06-22

  Explore how BKT140 (BL-8040) sets a new benchmark for CXCR4 antagonism in advanced oncology research. This in-depth analysis uniquely connects theranostic innovation with practical assay design and clinical translation.

• PD 0332991 (Palbociclib) HCl: Applied Workflows in Tumor Sup

  2026-06-21

  Leverage PD 0332991 (Palbociclib) HCl for precise G1 phase arrest and robust antiproliferative assays in Rb-positive cancer models. Discover protocol refinements, troubleshooting insights, and how new mechanistic findings unlock advanced applications in cell fate analysis.

14698 records 1/980 page Next 12345 下5页 Last page